Granahan Investment Management JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 125 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.

Granahan Investment Management ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,406
+8.7%
168,424
-3.3%
0.03%
+16.0%
Q3 2021$1,294
-46.8%
174,175
-51.3%
0.02%
-44.4%
Q2 2021$2,433
-30.1%
357,817
+5.6%
0.04%
-39.2%
Q1 2021$3,481
+24.3%
338,969
-15.3%
0.07%
+17.5%
Q4 2020$2,800
-27.2%
400,013
-15.2%
0.06%
-51.9%
Q3 2020$3,848
+8.1%
471,622
-8.6%
0.13%
+1.6%
Q2 2020$3,559
+183.6%
515,748
+95.3%
0.13%
+89.7%
Q1 2020$1,255
+17.5%
264,139
+116.0%
0.07%
+38.8%
Q4 2019$1,068
+161.1%
122,282
-0.5%
0.05%
+113.0%
Q3 2019$409
-28.9%
122,912
+5.9%
0.02%
-17.9%
Q2 2019$575
-26.1%
116,080
-7.5%
0.03%
-33.3%
Q1 2019$778
+75.6%
125,533
-4.5%
0.04%
+35.5%
Q4 2018$443
-49.6%
131,393
-2.9%
0.03%
-35.4%
Q3 2018$879
-12.8%
135,280
+2.8%
0.05%
-21.3%
Q2 2018$1,008
-62.6%
131,592
+9.1%
0.06%
-68.7%
Q1 2018$2,695
+79.1%
120,585
+2.1%
0.20%
+65.3%
Q4 2017$1,505118,0600.12%